Interaction of Hereditary Thrombophilia and Traditional Cardiovascular Risk Factors on the Risk of Arterial Thromboembolism: Pooled Analysis of Four Family Cohort Studies

Circulation: Cardiovascular Genetics

Volumn 9, Issue 1, 2016, Pages 79-85

  Mahmoodi, Bakhtawar K ^a,b   Veeger, Nic J G M ^b   Middeldorp, Saskia ^c   Lijfering, Willem M ^d   Brouwer, Jan Leendert P ^e   Ten Berg, Jur ^a   Hamulyák, Karly ^f   Meijer, Karina ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e De Sionsberg Hospital ^*  (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

arterial thrombosis; cardiovascular disease; epidemiology; factor V Leiden; hereditary thrombophilia; protein C deficiency; protein S deficiency; prothrombin G20210A

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; PROTEIN C; PROTEIN S; PROTHROMBIN; PLASMA PROTEIN;

ADULT; AGE; ANTICOAGULANT PROTEIN DEFICIENCY; ANTITHROMBIN DEFICIENCY; ARTERIAL THROMBOEMBOLISM; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN C DEFICIENCY; PROTEIN DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN DEFICIENCY; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; THROMBOPHILIA; TRANSIENT ISCHEMIC ATTACK; FAMILY; GENETICS; RISK FACTOR; THROMBOEMBOLISM;

ADULT; BLOOD PROTEINS; COHORT STUDIES; FAMILY; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 84959558534     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.115.001211     Document Type: Article

References (23)

1. Mahmoodi BK, Brouwer JL, Ten Kate MK, Lijfering WM, Veeger NJ, Mulder AB, A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. J Thromb Haemost 2010 8 1193 1200. doi: 10.1111/j.1538-7836.2010.03840.x.
2. Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood 2009 113 5314 5322. doi: 10.1182/blood-2008-10-184879.
3. Brouwer JL, Veeger NJ, Kluin-Nelemans HC, van der Meer J., The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes. Ann Intern Med 2006 145 807 815
4. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006 367 651 658. doi: 10.1016/S0140-6736(06)68263-9.
5. Mahmoodi BK, Brouwer JL, Veeger NJ, van der Meer J., Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation 2008 118 1659 1667. doi: 10.1161/CIRCULATIONAHA.108.780759.
6. Mackman N., Triggers, targets and treatments for thrombosis. Nature 2008 451 914 918. doi: 10.1038/nature06797.
7. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL., A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997 90 1747 1750
8. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT Jr, Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997 89 2817 2821
9. Inbal A, Freimark D, Modan B, Chetrit A, Matetzky S, Rosenberg N, Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood 1999 93 2186 2190
10. Doggen CJ, Cats VM, Bertina RM, Rosendaal FR., Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998 97 1037 1041
11. Ridker PM, Hennekens CH, Miletich JP., G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999 99 999 1004
12. Borecki IB, Province MA., Genetic and genomic discovery using family studies. Circulation 2008 118 1057 1063. doi: 10.1161/CIRCULATIONAHA.107.714592.
13. Lijfering WM, Veeger NJ, Brouwer JL, van der Meer J., The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels. Haematologica 2007 92 1703 1706. doi: 10.3324/haematol.11611.
14. Bank I, van de Poel MH, Coppens M, Hamulyák K, Prins MH, van der Meer J, Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study. Thromb Haemost 2007 98 1040 1044
15. Bank I, Libourel EJ, Middeldorp S, Van Pampus EC, Koopman MM, Hamulyák K, Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med 2004 164 1932 1937. doi: 10.1001/archinte.164.17.1932.
16. Catena C, Colussi G, Nait F, Capobianco F, Sechi LA., Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients. Am J Hypertens 2015 28 943 950. doi: 10.1093/ajh/hpu248.
17. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH., The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis 2005 181 101 108. doi: 10.1016/j.atherosclerosis.2004.12.031.
18. Knol MJ, VanderWeele TJ, Groenwold RH, Klungel OH, Rovers MM, Grobbee DE., Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011 26 433 438. doi: 10.1007/s10654-011-9554-9.
19. Roshani S, Lijfering WM, Coppens M, Hamulyák K, Prins MH, Büller HR, Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolism. Neth J Med 2011 69 27 30
20. Maas AH, Appelman YE., Gender differences in coronary heart disease. Neth Heart J 2010 18 598 602
21. Hainer V, Aldhoon-Hainerová I., Obesity paradox does exist. Diabetes Care 2013 36 suppl 2 S276 S281. doi: 10.2337/dcS13-2023.
22. Ko DT, Mamdani M, Alter DA., Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 2004 291 1864 1870. doi: 10.1001/jama.291.15.1864.
23. Morimoto LM, White E, Newcomb PA., Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol 2003 158 259 263